These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8945532)

  • 1. Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes.
    Egan AM; Gordon DL
    Infect Immun; 1996 Dec; 64(12):4952-9. PubMed ID: 8945532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils.
    Woodman ME; Worth RG; Wooten RM
    PLoS One; 2012; 7(12):e52276. PubMed ID: 23251706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophages.
    Mulye M; Bechill MP; Grose W; Ferreira VP; Lafontaine ER; Wooten RM
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e2988. PubMed ID: 25144195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
    Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
    J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
    Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J
    J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies.
    Ho M; Schollaardt T; Smith MD; Perry MB; Brett PJ; Chaowagul W; Bryan LE
    Infect Immun; 1997 Sep; 65(9):3648-53. PubMed ID: 9284132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis.
    Ben Nasr A; Klimpel GR
    J Leukoc Biol; 2008 Jul; 84(1):77-85. PubMed ID: 18430786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shigella sonnei phase I and phase II: susceptibility to direct serum lysis and opsonic requirements necessary for stimulation of leukocyte redox metabolism and killing.
    Madonna GS; Allen RC
    Infect Immun; 1981 Apr; 32(1):153-9. PubMed ID: 7012027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice.
    Su YC; Wan KL; Mohamed R; Nathan S
    Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsonization of yeast cells with equine iC3b, C3b, and IgG.
    Gröndahl G; Johannisson A; Jensen-Waern M; Nilsson Ekdahl K
    Vet Immunol Immunopathol; 2001 Aug; 80(3-4):209-23. PubMed ID: 11457475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects.
    Chanchamroen S; Kewcharoenwong C; Susaengrat W; Ato M; Lertmemongkolchai G
    Infect Immun; 2009 Jan; 77(1):456-63. PubMed ID: 18955471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killing of Pseudomonas pseudomallei by polymorphonuclear leukocytes and peritoneal macrophages from chicken, sheep, swine and rabbits.
    Markova N; Kussovski V; Radoucheva T
    Zentralbl Bakteriol; 1998 Jul; 288(1):103-10. PubMed ID: 9728410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition.
    Reckseidler-Zenteno SL; DeVinney R; Woods DE
    Infect Immun; 2005 Feb; 73(2):1106-15. PubMed ID: 15664954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis.
    Wiersinga WJ; Kager LM; Hovius JW; van der Windt GJ; de Vos AF; Meijers JC; Roelofs JJ; Dondorp A; Levi M; Day NP; Peacock SJ; van der Poll T
    J Immunol; 2010 Mar; 184(6):3079-86. PubMed ID: 20142364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway.
    Verbrugh HA; Lee DA; Elliott GR; Keane WF; Hoidal JR; Peterson PK
    Immunology; 1985 Apr; 54(4):643-53. PubMed ID: 3980045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalis.
    Cutler CW; Kalmar JR; Arnold RR
    Infect Immun; 1991 Jun; 59(6):2105-9. PubMed ID: 2037371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin.
    Gemmell CG; Peterson PK; Schmeling D; Kim Y; Mathews J; Wannamaker L; Quie PG
    J Clin Invest; 1981 May; 67(5):1249-56. PubMed ID: 7014632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium.
    Rakita RM; Quan VC; Jacques-Palaz K; Singh KV; Arduino RC; Mee M; Murray BE
    FEMS Immunol Med Microbiol; 2000 Aug; 28(4):291-9. PubMed ID: 10891652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
    Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
    Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.